My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Priorix - Powder and solvent for solution for injection in a pre-filled syringeMeasles, Mumps and Rubella vaccine (live)



GlaxoSmithKline (Ireland) LimitedPA1077/036/001

Main Information

Trade NamePriorix - Powder and solvent for solution for injection in a pre-filled syringeMeasles, Mumps and Rubella vaccine (live)
Active SubstancesMeasles virus - schwarz strain live attenuated
Mumps vaccine rit 4385 live attenuated
Rubella virus (ra 27/3 strain)
Dosage FormPowder and solvent for solution for injection in pre-filled syringe
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/036/001

Group Information

ATC CodeJ07BD Measles vaccines
J07BD52 measles, combinations with mumps and rubella, live attenuated

Status

License statusAuthorised
Licence Issued27/07/1998
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceBatches of Vaccine marketed in Ireland shall be subject to control authority batch release in accordance 114.1 of Directive 2001/83/EC.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print